Clinical Data Acquired by the PURE EP™ System Published in the Journal of Cardiovascular Electrophysiology
04 oct. 2021 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Oct. 04, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company developing a proprietary biomedical signal...
BioSig Selects Plexus Corp. as its Manufacturing Partner
28 sept. 2021 09h15 HE
|
BioSig Technologies, Inc.
Westport, CT, Sept. 28, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors
21 sept. 2021 10h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Sept. 21, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Global Organ Care System for Heart Market Anticipated to Garner a Revenue of $44.02 Million at a CAGR of 19.4% during the Forecast Period, 2019-2026 COVID-19 Disaster - Exclusive Report by Research Dive
21 sept. 2021 09h30 HE
|
Research Dive
New York, USA, Sept. 21, 2021 (GLOBE NEWSWIRE) -- According to a recent report by Research Dive, the global organ care system for heart market is forecasted to reach $44.02 million by the end of...
BioSig Increases Installation Footprint Adding St. Elizabeth’s Medical Center to Roster of Premium Medical Institutions Utilizing the PURE EP System
13 sept. 2021 08h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Sept. 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Global Organ Care System for Heart Market Expected to Garner Revenue of $37.2 Million by 2026 at a CAGR of 16.5% from 2019-2026 - Exclusive Report [90-Pages] by Research Dive
08 sept. 2021 09h00 HE
|
Research Dive
New York, USA, Sept. 08, 2021 (GLOBE NEWSWIRE) -- The latest report by Research Dive states that the global organ care system for heart market is predicted to witness a rise in revenue from $11.0...
BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Symposium
31 août 2021 10h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 31, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig’s Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium
19 août 2021 11h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 19, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig To Host Presentations from Physician Users of its Signal Processing System for Arrhythmia Care during the annual Heart Rhythm 2021 convention
20 juil. 2021 14h00 HE
|
BioSig Technologies, Inc.
Westport, CT, July 20, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig Latest Installation Broadens Clinical Footprint for its Signal Processing Technology for Electrophysiology
13 juil. 2021 14h30 HE
|
BioSig Technologies, Inc.
Westport, CT, July 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...